Key points of clinical diagnosis and treatment of special types of hypertension

doi:10.12114/j.issn.1007-9572.2020.00.221

Abstract

Key words: Hypertension, Special type of hypertension, Disease management, Diagnostic criteria, Drug therapy, Non drug treatment

关键词: 高血压, 特殊类型高血压, 疾病管理, 诊断标准, 药物疗法, 非药物治疗

Hypertension Specialist Committee of Expert Committee on Prevention and Rehabilitation of Cardiovascular Diseases. Key points of clinical diagnosis and treatment of special types of hypertension[J]. Chinese General Practice, 2020, 23(10): 1202-1228.

中国中医药研究促进会中西医结合心血管病预防与康复专业委员会高血压专家委员会, 北京高血压防治协会, 中国高血压联盟, 北京大学医学部血管健康研究中心. 特殊类型高血压临床诊治要点专家建议[J]. 中国全科医学, 2020, 23(10): 1202-1228.

References

［1］WHELTON P K，CAREY R M，ARONOW W S，et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention，detection，evaluation，and management of high blood pressure in adults：a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines［J］. Journal of the American College of Cardiology，2018，71（19）：e127-248.
［2］WILLIAMS B，MANCIA G，SPIERING W，et al. 2018 ESC/ESH guidelines for the management of arterial hypertension：the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension：the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension［J］.Journal of Hypertension，2018，36（10）：1953-2041. DOI：10.1097/HJH.0000000000001940.
［3］中国高血压防治指南修订委员会，高血压联盟（中国），中华医学会心血管病学分会，等. 中国高血压防治指南（2018年修订版）［J］. 中国心血管杂志，2019，24（1）：24-56. DOI：10.3969/j.issn.1007-5410.2019.01.002.
Writing Group of 2018 Chinese Guidelines for the Management of Hypertension，Chinese Hypertension League，Chinese Society of Cardiology，et al. 2018 Chinese guidelines for the management of hypertension［J］. Chinese Journal of Cardiovascular Medicine，2019，24（1）：24-56. DOI：10.3969/j.issn.1007-5410.2019.01.002.
［4］陈琦玲，李瑞杰. 特殊类型高血压的诊断与治疗［M］. 北京：北京大学医学出版社，2017.
［5］原国家卫生计生委疾病预防控制局. 中国居民营养与慢性病状况报告（2015）［M］. 北京：人民卫生出版社，2015.
［6］中国老年学和老年医学学会心脑血管病专业委员会，中国医师协会心血管内科医师分会. 老年高血压的诊断与治疗中国专家共识（2017 版）［J］. 中华内科杂志，2017，56（11）：885-893. DOI：10.3760/cma.j.issn.0578-1426.2017.11.00.024.
Cardio Cerebrovascular Diseases Professional Committee of China Association of Gerontology and Geriatrics，Chinese College of Cardiovascular Physicians. Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly（2017）［J］. Chinese Journal of Internal Medicine，2017，56（11）：885-893. DOI：10.3760/cma.j.issn.0578-1426.2017.11.00.024.
［7］IADECOLA C，YAFFE K，BILLER J，et al. Impact of hypertension on cognitive function：a scientific statement from the American Heart Association［J］. Hypertension，2016，68（6）：e67-94.
［8］JORDAN J，FANCIULLI A，TANK J，et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension：scientific statement of the American Autonomic Society，European Federation of Autonomic Societies，and the European Society of Hypertension［J］. Journal of Hypertension，2019，37（8）：1541-1546. DOI：10.1097/HJH.0000000000002078.
［9］BENETOS A，BULPITT C J，PETROVIC M，et al. An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old，frail subjects［J］. Hypertension，2016，67（5）：820-825. DOI：10.1161/HYPERTENSIONAHA.115.07020.
［10］KIT B K，KUKLINA E，CARROLL M D，et al. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents，1999—2012［J］. JAMA Pediatrics，2015，169（3）：272-279. DOI：10.1001/jamapediatrics.2014.3216.
［11］DONG B，MA J，WANG H J，et al. The association of overweight and obesity with blood pressure among Chinese children and adolescents［J］. Biomedical and Environmental Sciences，2013，26（6）：437-444. DOI：10.3967/0895-3988.2013.06.004.
［12］范晖，闫银坤，米杰. 中国 3~17 岁儿童性别、年龄别和身高别血压参照标准［J］. 中华高血压杂志，2017，25（5）：428-435.
FAN H，YAN Y K，MI J. Updating blood pressure references for Chinese children aged 3-17 years［J］. Chinese Journal of Hypertension，2017，25（5）：428-435.
［13］张仪，齐建光，肖慧捷，等. 275 例住院儿童高血压的病因及临床分析［J］. 中国医刊，2014，49（12）：45-48. DOI：10.3969/j.issn.1008-1070.2014.12.017.
ZHANG Y，QI J G，XIAO H J，et al. Etiology and clinical analysis of 275 admitted children with hypertension［J］. Chinese Journal of Medicine，2014，49（12）：45-48. DOI：10.3969/j.
issn.1008-1070.2014.12.017.
［14］KAPUR G，AHMED M，PAN C，et al. Secondary hypertension in overweight and stage 1 hypertensive children：a midwest pediatric nephrology consortium report［J］. J Clin Hypertens（Greenwich），2010，12（1）：34-39. DOI：10.1111/j.1751-7176.2009.00195.x.
［15］胡文娟，齐建光. 2017 年美国儿科学会《儿童青少年高血压筛查和管理的临床实践指南》解读及对我国全科医师的指导建议［J］. 中国全科医学，2019，22（24）：2897-2906. DOI：10.12114/j.issn.1007-9572.2019.00.339.
HU W J，QI J G. Interpretation of 2017 AAP clinical practice guideline for screening and management of high blood pressure in children and adolescents and suggestions for general practitioners in China［J］. Chinese General Practice，2019，22（24）：2897-2906. DOI：10.12114/j.issn.1007-9572.2019.00.339.
［16］TAYLOR S D，BAGOZZI R P，GAITHER C A. Gender differences in the self-regulation of hypertension［J］. Journal of Behavioral Medicine，2001，24（5）：469-487.
［17］苟文丽. 妊娠期高血压疾病［M］// 妇产科学. 6 版. 北京：人民卫生出版社，2004.
［18］PECHEREBERTSCHI A，BURNIER M. Female sex hormones，salt，and blood pressure regulation［J］. Am J Hypertens，2004，17（10）：994-1001. DOI：10.1016/j.amjhyper.2004.08.009.
［19］WOLFSTHAL S D. Is blood pressure control necessary before surgery?［J］. Med Clin N Am，1993，77（2）：349-363. DOI：10.1016/s0025-7125（16）30256-5.
［20］GOLDMAN L，CALDERA D L. Risks of general anesthesia and elective operation in the hypertensive patient［J］. Anesthesiology，1979，50（4）：285-292. DOI：10.1097/00000542-197904000-00002.
［21］GAL T J，COOPERMAN L H. Hypertension in the immediate postoperative period［J］. Br J Anaesth，1975，47（1）：70-74. DOI：10.1093/bja/47.1.70.
［22］中国心胸血管麻醉学会，北京高血压防治协会. 围术期高血压管理专家共识［J］. 临床麻醉学杂志，2016，32（3）：295-297. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcmzxzz201603032.
［23］SELLEVOLD O F，RAEDER J，STENSETH R. Undiagnosed phaeochromocytoma in the perioperative period. Case reports［J］. Acta Anaesthesiol Scand，1985，29（5）：474-479. DOI：10.1111/j.1399-6576.1985.tb02236.x.
［24］HARTLE A，MCCORMACK T，CARLISLE J，et al. The measurement of adult blood pressure and management of hypertension before elective surgery：joint guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society［J］. Anaesthesia，2016，71（3）：326-337. DOI：10.1111/anae.13348.
［25］CHATTERJEE S，BAVISHI C，SARDAR P，et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias［J］. Am J Cardiol，2014，114（7）：1049-1052. DOI：10.1016/j.amjcard.2014.07.015.
［26］LIP G Y，LAROCHE C，DAN G A，et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management：baseline results of EURObservational Research Programme Atrial Fibrillation（EORP-AF） Pilot General Registry［J］. Europace，2014，16（3）：308-319. DOI：10.1093/europace/eut373.
［27］LIP G Y H，COCA A，KAHAN T，et al. Hypertension and cardiac arrhythmias：executive summary of a consensus document from the European Heart Rhythm Association（EHRA） and ESC Council on Hypertension，endorsed by the Heart Rhythm Society（HRS），Asia-Pacific Heart Rhythm Society（APHRS），and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología（SOLEACE）［J］. Eur Heart J Cardiovasc Pharmacother，2017，3（4）：235-250. DOI：10.1093/ehjcvp/pvx019.
［28］JAMES P A，OPARIL S，CARTER B L，et al. 2014 evidence-based guideline for the management of high blood pressure in adults：report from the panel members appointed to the Eighth Joint National Committee（JNC 8）［J］. JAMA，2014，311（5）：507-520. DOI：10.1001/jama.2013.284427.
［29］MANCIA G，FAGARD R，NARKIEWICZ K，et al. 2013 ESH/ESC guidelines for the management of arterial hypertension：the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension（ESH） and of the European Society of Cardiology（ESC）［J］. Eur Heart J，2013，34（28）：2159-2219. DOI：10.1093/eurheartj/eht151.
［30］JANUARY C T，WANN L S，ALPERT J S，et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation：a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society［J］. Circulation，2014，130（23）：e199-267. DOI：10.1161/CIR.0000000000000041.
［31］ROSENDORFF C，LACKLAND D T，ALLISON M，et al. Treatment of hypertension in patients with coronary artery disease：a scientific statement from the American Heart Association，American College of Cardiology，and American Society of Hypertension［J］. J Am Coll Cardiol，2015，65（18）：1998-2038. DOI：10.1016/j.jacc.2015.02.038.
［32］中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组，中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南［J］. 中华心血管病杂志，2017，45（12）：1015-1032. DOI：10.3760/cma.j.issn.0253-3758.2017.12.005. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhxxgb201712006.
［33］胡盛寿，高润霖，刘力生，等. 《中国心血管病报告 2018》概要［J］. 中国循环杂志，2019，34（3）：209-220. DOI：10.3969/j.issn.1000-3614.2019.03.001.
HU S S，GAO R L，LIU L S，et al. Summary of the 2018 report on cardiovascular diseases in China［J］. Chinese Circulation Journal，2019，34（3）：209-220. DOI：10.3969/j.issn.1000-3614.2019.03.001.
［34］中国医师协会肾脏内科医师分会，中国中西医结合学会肾脏疾病专业委员会. 中国肾性高血压管理指南2016（简版）［J］. 中华医学杂志，2017，97（20）：1547-1555. DOI：10.3760/cma.j.issn.0376-2491.2017.20.010. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201720011.
［35］ROBERTS M A. Commentary on the KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease［J］. Nephrology，2014，19（1）：53-55. DOI：10.1111/nep.12168.
［36］中国医疗保健国际交流促进会血管疾病高血压分会专家共识起草组. 肾动脉狭窄的诊断和处理中国专家共识［J］. 中国循环杂志，2017，32（9）：835-844. DOI：10.3969/j.issn.1000-3614.2017.09.002.
［37］中华医学会内分泌学分会肾上腺学组. 原发性醛固酮增多症诊断治疗的专家共识［J］. 中华内分泌代谢杂志，2016，32（3）：188-195. DOI：10.3760/cma.j.issn.1000-6699.2016.03.003.
［38］中华医学会内分泌学分会肾上腺学组. 嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识［J］. 中华内分泌代谢杂志，2016，32（3）：181-187. DOI：10.3760/cma.j.issn.1000-6699.2016.03.002.
［39］中国垂体腺瘤协作组. 中国库欣病诊治专家共识（2015）［J］. 中华医学杂志，2016，96（11）：835-840. DOI：10.3760/cma.j.issn.0376-2491.2016.11.002. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201611002.
［40］SARAFIDIS P A，PERSU A，AGARWAL R，et al. Hypertension in dialysis patients：a consensus document by the European Renal and Cardiovascular Medicine（EURECA-m）Working Group of the European Renal Association - European Dialysis and Transplant Association（ERA-EDTA）and the Hypertension and the Kidney Working Group of the European Society of Hypertension（ESH）［J］. J Hypertens，2017，35（4）：657-676. DOI：10.1097/HJH.0000000000001283.
［41］LEE M S，LEE J S，LEE J Y. Prevention of erythropoietin-associated hypertension［J］. Hypertension，2007，50（2）：439-445. DOI：10.1161/hypertensionaha.107.090423.
［42］NAKHOUL G，SIMON J F. Anemia of chronic kidney disease：treat it，but not too aggressively［J］. Cleve Clin J Med，2016，83（8）：613-624. DOI：10.3949/ccjm.83a.15065.
［43］中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南 2014［J］. 中华神经科杂志，2015，48（4）：246-257. DOI：10.3760/cma.j.issn.1006-7876.2015.04.002. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx201611002.
［44］陈琦玲，刘晴. 以高血压首诊的颅内肿瘤一例［J］. 中华心脏与心律电子杂志，2014，2（2）：152. DOI：10.3877/cma.j.issn.2095-6568.2014.2.022.
CHEN Q L，LIU Q. A case of intracranial tumor first diagnosed with hypertension［J］. Chinese Journal of Heart and Heart Rhythm：Electronic Edition，2014，2（2）：152. DOI：10.3877/cma.j.issn.2095-6568.2014.2.022.
［45］DRAGER L F，GENTA P R，PEDROSA R P，et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension［J］. Am J Cardiol，2010，105（8）：1135-1139. DOI：10.1016/j.amjcard.2009.12.017.
［46］LOGAN A G，PERLIKOWSKI S M，MENTE A，et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension［J］. J Hypertens，2001，19（12）：2271-2277. DOI：10.1097/00004872-200112000-00022.
［47］CHOBANIAN A V，BAKRIS G L，BLACK H R，et al. The seventh report of the joint national committee on prevention，detection，evaluation，and treatment of high blood pressure：the JNC 7 report［J］. JAMA，2003，289（19）：2560-2572. DOI：10.1001/jama.289.19.2560.
［48］杨晶晶，李南方，王红梅. 阻塞性睡眠呼吸暂停综合征相关交感神经递质的研究进展［J］. 临床和实验医学杂志，2010，9（8）：632-633. DOI：10.3969/j.issn.1671-4695.2010.08.045. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lchsyyxzz201008045.
［49］LI N F，YAO X G，ZHU J，et al. Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome［J］. Clin Exp Hypertens，2010，32（1）：54-60. DOI：10.3109/10641960902993087.
［50］NICHOLL D D M，HANLY P J，ZALUCKY A A，et al. CPAP therapy delays cardiovagal reactivation and decreases arterial renin-angiotensin system activity in humans with obstructive sleep apnea［J］. J Clin Sleep Med，2018，14（9）：1509-1520. DOI：10.5664/jcsm.7326.
［51］KUSHIDA C A，MORGENTHALER T I，LITTNER M R，et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances：an update for 2005［J］. Sleep，2006，29（2）：240-243. DOI：10.1093/sleep/29.2.240.
［52］HAENTJENS P，VAN MEERHAEGHE A，MOSCARIELLO A，et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome：evidence from a meta-analysis of placebo-controlled randomized trials［J］. Arch Intern Med，2007，167（8）：757-764. DOI：10.1001/archinte.167.8.757.
［53］李莉，吴海英，刘力生. 睡眠呼吸暂停综合征与高血压治疗［J］. 中华心血管病杂志，2004，32（1）：30-32. DOI：10.3760/j.issn.0253-3758.2004.01.010.
LI L，WU H Y，LIU L S. Sleep apnea syndrome and hypertension treatment［J］. Chinese Journal of Cardiology，2004，32（1）：30-32. DOI：10.3760/j.issn.0253-3758.2004.01.010.
［54］GAINES J，VGONTZAS A N，FERNANDEZ-MENDOZA J，et al. Inflammation mediates the association between visceral adiposity and obstructive sleep apnea in adolescents［J］. Am J Physiol Endocrinol Metab，2016，311（5）：e851-858. DOI：10.1152/ajpendo.00249.2016.
［55］WU E L，CHIEN I C，LIN C H，et al. Increased risk of hypertension in patients with major depressive disorder：a population-based study［J］. J Psychosom Res，2012，73（3）：169-174. DOI：10.1016/j.jpsychores.2012.07.002.
［56］VETERE G，RIPALDI L，AIS E，et al. Prevalence of anxiety disorders in patients with essential hypertension［J］. Vertex，2007，18（71）：20-25.
［57］李晓丽，毛家亮. 原发性高血压与心理障碍的研究现状［J］. 心血管病学进展，2007，28（3）：422-425. DOI：10.3969/j.issn.1004-3934.2007.03.028.
LI X L，MAO J L. Current study of essential hypertension and mental disorders［J］. Advances in Cardiovascular Diseases，2007，28（3）：422-425. DOI：10.3969/j.issn.1004-3934.2007.03.028.
［58］DE BOER I H，BANGALORE S，BENETOS A，et al. Diabetes and hypertension：a position statement by the American Diabetes Association［J］. Diabetes Care，2017，40（9）：1273-1284. DOI：10.2337/dci17-0026.
［59］原国家卫生计生委合理用药专家委员会，中国医师协会高血压专业委员会. 高血压合理用药指南（第 2 版）［J］. 中国医学前沿杂志：电子版，2017，9（7）：28-126. DOI：10.12037/YXQY.2017.07-07. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxqyzz201707008#.
［60］SONG J，HU X Q，RIAZI S，et al. Regulation of blood pressure，the epithelial sodium channel（ENaC），and other key renal sodium transporters by chronic insulin infusion in rats［J］. Am J Physiol Renal Physiol，2006，290（5）：F1055-1064. DOI：10.1152/ajprenal.00108.2005.
［61］COOPER S A，WHALEY-CONNELL A，HABIBI J，et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance［J］. Am J Physiol Heart Circ Physiol，2007，293（4）：H2009-2023. DOI：10.1152/ajpheart.00522.2007.
［62］FAGOT-CAMPAGNA A，BALKAU B，SIMON D，et al. Is insulin an independent risk factor for hypertension? The Paris Prospective Study［J］. Int J Epidemiol，1997，26（3）：542-550. DOI：10.1093/ije/26.3.542.
［63］李云，杨鹏，武英，等. 原发性高血压患者肾素-血管紧张素-醛固酮系统活性与空腹血糖水平的关系［J］. 中国糖尿病杂志，2014，22（2）：135-137. DOI：10.3969/j.issn.1006-6187.2014.02.012.
LI Y，YANG P，WU Y，et al. Relationship between renin-angiotensin-aldosterone system and glucose levels in patients with essential hypertensive［J］. Chinese Journal of Diabetes，2014，22（2）：135-137. DOI：10.3969/j.issn.1006-6187.2014.02.012.
［64］叶达平，王力. 高血压住院患者病因及危险因素分析［J］. 中西医结合心脑血管病杂志，2013，11（11）：1305-1306. DOI：10.3969/j.issn.1672-1349.2013.11.015.
YE D P，WANG L. Analysis of the etiology and risk factors of hypertension inpatients［J］. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease，2013，11（11）：1305-1306. DOI：10.3969/j.issn.1672-1349.2013.11.015.
［65］PRISANT L M，GUJRAL J S，MULLOY A L. Hyperthyroidism：a secondary cause of isolated systolic hypertension［J］. J Clin Hypertens（Greenwich），2006，8（8）：596-599. DOI：10.1111/j.1524-6175.2006.05180.x.
［66］KLEIN I，DANZI S. Thyroid disease and the heart［J］. Circulation，2007，116（15）：1725-1735. DOI：10.1161/circulationaha.106.678326.
［67］PARKER V J，GILOR C，CHEW D J. Feline hyperparathyroidism：pathophysiology，diagnosis and treatment of primary and secondary disease［J］. J Feline Med Surg，2015，17（5）：427-439. DOI：10.1177/1098612X15581134.
［68］中华医学会骨质疏松和骨矿盐疾病分会，中华医学会内分泌分会代谢性骨病学组. 原发性甲状旁腺功能亢进症诊疗指南［J］. 中华骨质疏松和骨矿盐疾病杂志，2014，7（3）：187-198. DOI：10.3969/j.issn.1674-2591.2014.03.002. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhgzsshgkyjbzz201403003.
［69］GRAFF-BAKER A N，BRIDGES L T，CHEN Q L，et al. Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension［J］. JAMA Surg，2019. DOI：10.1001/jamasurg.2019.3950.
［70］罗飞宏. 先天性肾上腺皮质增生症诊断治疗进展［J］. 中华实用儿科临床杂志，2015，30（8）：564-569. DOI：10.3760/cma.j.issn.2095-428X.2015.08.002.
LUO F H. Progress of diagnosis and clinical management of congenital adrenal hyperplasia［J］. Chinese Journal of Applied Clinical Pediatrics，2015，30（8）：564-569. DOI：10.3760/cma.j.issn.2095-428X.2015.08.002.
［71］HINZ L，PACAUD D，KLINE G. Congenital adrenal hyperplasia causing hypertension：an illustrative review［J］. J Hum Hypertens，2018，32（2）：150-157. DOI：10.1038/s41371-017-0002-5.
［72］HOWARD D P，BANERJEE A，FAIRHEAD J F，et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control：10-year results from the Oxford Vascular Study［J］. Circulation，2013，127（20）：2031-2037. DOI：10.1161/CIRCULATIONAHA.112.000483.
［73］OLSSON C，THELIN S，STÅHLE E，et al. Thoracic aortic aneurysm and dissection：increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14 000 cases from 1987 to 2002［J］. Circulation，2006，114（24）：2611-2618. DOI：10.1161/CIRCULATIONAHA.106.630400.
［74］ERBEL R，ABOYANS V，BOILEAU C，et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases：document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology（ESC）［J］. Eur Heart J，2014，35（41）：2873-2926. DOI：10.1093/eurheartj/ehu281.
［75］王辰，王建安. 内科学［M］. 3 版. 北京：人民卫生出版社，2015.
［76］HIRATZKA L F，BAKRIS G L，BECKMAN J A，et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American college of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines，American Association for Thoracic Surgery，American College of Radiology，American Stroke Association，Society of Cardiovascular Anesthesiologists，Society for Cardiovascular Angiography and Interventions，Society of Interventional Radiology，Society of Thoracic Surgeons，and Society for Vascular Medicine［J］. J Am Coll Cardiol，2010，55（14）：e27-129. DOI：10.1016/j.jacc.2010.02.015.
［77］MOKASHI S A，SVENSSON L G. Guidelines for the management of thoracic aortic disease in 2017［J］. Gen Thorac Cardiovasc Surg，2019，67（1）：59-65. DOI：10.1007/s11748-017-0831-8.
［78］GADDUM N R，KEEHN L，GUILCHER A，et al. Altered dependence of aortic pulse wave velocity on transmural pressure in hypertension revealing structural change in the aortic wall［J］. Hypertension，2015，65（2）：362-369. DOI：10.1161/HYPERTENSIONAHA.114.04370.
［79］WHELTON P K，CAREY R M，ARONOW W S，et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/Apha/ASH/ASPC/NMA/
PCNA guideline for the prevention，detection，evaluation，and management of high blood pressure in adults：executive summary：a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines［J］. Hypertension，2018，71（6）：1269-1324. DOI：10.1161/HYP.0000000000000066.
［80］DELSART P，LEDIEU G J，RAMDANE N，et al. Impact of the management of type B aortic dissection on the long-term blood pressure［J］. Am J Cardiol，2017，120（3）：484-488. DOI：10.1016/j.amjcard.2017.04.052.
［81］ZHANG L，TIAN W，FENG R，et al. Prognostic impact of blood pressure variability on aortic dissection patients after endovascular therapy［J］. Medicine（Baltimore），2015，94（38）：e1591. DOI：10.1097/MD.0000000000001591.
［82］KONDO N，TAMURA K，HIRAOKA A，et al. Treatment outcomes for acute type A aortic dissection with patent false lumen in patients over the age of 80［J］. Gen Thorac Cardiovasc Surg，2019，67（9）：765-772. DOI：10.1007/s11748-019-01111-9.
［83］THIJSSEN C G E，BONS L R，GÖKALP A L，et al. Exercise and sports participation in patients with thoracic aortic disease：a review［J］. Expert Rev Cardiovasc Ther，2019，17（4）：251-266. DOI：10.1080/14779072.2019.1585807.
［84］FOWKES F G，ABOYANS V，FOWKES F J，et al. Peripheral artery disease：epidemiology and global perspectives［J］. Nat Rev Cardiol，2017，14（3）：156-170. DOI：10.1038/nrcardio.2016.179.
［85］FOWKES F G，RUDAN D，RUDAN I，et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010：a systematic review and analysis［J］. Lancet，2013，382（9901）：1329-1340. DOI：10.1016/S0140-6736（13）61249-0.
［86］ABOYANS V，RICCO J B，BARTELINK M E L，et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases，in collaboration with the European Society for Vascular Surgery（ESVS）：document covering atherosclerotic disease of extracranial carotid and vertebral，mesenteric，renal，upper and lower extremity arteries endorsed by the European Stroke Organization（ESO）The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology（ESC） and of the European Society for Vascular Surgery（ESVS）［J］. Eur Heart J，2018，39（9）：763-816. DOI：10.1093/eurheartj/ehx095.
［87］GRØNDAL N，SØGAARD R，LINDHOLT J S. Baseline prevalence of abdominal aortic aneurysm，peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study（VIVA trial）［J］. Br J Surg，2015，102（8）：902-906. DOI：10.1002/bjs.9825.
［88］GERHARD-HERMAN M D，GORNIK H L，BARRETT C，et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease：a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines［J］. Circulation，2017，135（12）：e726-779. DOI：10.1161/CIR.0000000000000471.
［89］PENG M，JIANG X J，DONG H，et al. Etiology of renal artery stenosis in 2 047 patients：a single-center retrospective analysis during a 15-year period in China［J］. J Hum Hypertens，2016，30（2）：124-128. DOI：10.1038/jhh.2015.40.
［90］ROSS E J，LINCH D C. Cushing's syndrome——killing disease：discriminatory value of signs and symptoms aiding early diagnosis［J］. Lancet，1982，2（8299）：646-649. DOI：10.1016/s0140-6736（82）92749-0.
［91］SAVAGE O，COPEMAN W S，CHAPMAN L，et al. Pituitary and adrenal hormones in rheumatoid arthritis［J］. Lancet，1962，1（7223）：232-235.
［92］TREADWELL B L J，SEVER E D，SAVAGE O，et al. Side-effects of long-term treatment with corticosteroids and corticotrophin［J］. Lancet，1964，283（7343）：1121-1123. DOI：10.1016/s0140-6736（64）91804-5.
［93］GROSSMAN A，MESSERLI F H，GROSSMAN E. Drug induced hypertension——an unappreciated cause of secondary hypertension［J］. Eur J Pharmacol，2015，763（Pt A）：15-22. DOI：10.1016/j.ejphar.2015.06.027.
［94］中华医学会风湿病学分会. 大动脉炎诊断及治疗指南［J］. 中华风湿病学杂志，2011，15（2）：119-120. DOI：10.3760/cma.j.issn.1007-7480.2011.02.013. http：//www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfs
bx98201102013.
［95］YEH E T H，BICKFORD C L. Cardiovascular complications of cancer therapy［J］. J Am Coll Cardiol，2009，53（24）：2231-2247. DOI：10.1016/j.jacc.2009.02.050.
［96］谢良地，吴可贵，许能锋，等. 高血压病人发生肿瘤危险性的研究［J］. 高血压杂志，1998，6（4）：252-256. DOI：10.16439/j.cnki.1673-7245.1998.04.006.
XIE L D，WU K G，XU N F，et al. Study on cancer risk in hypertension［J］. Chinese Journal of Hypertension，1998，6（4）：252-256. DOI：10.16439/j.cnki.1673-7245.1998.04.006.
［97］STOCKS T，VAN HEMELRIJCK M，MANJER J，et al. Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project［J］. Hypertension，2012，59（4）：802-810. DOI：10.1161/HYPERTENSIONAHA.111.189258.
［98］SANFILIPPO K M，MCTIGUE K M，FIDLER C J，et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women［J］. Hypertension，2014，63（5）：934-941. DOI：10.1161/HYPERTENSIONAHA.113.02953.
［99］DE SOUZA V B，SILVA E N，RIBEIRO M L，et al. Hypertension in patients with cancer［J］. Arquivos Brasileiros De Cardiol，2015. DOI：10.5935/abc.20150011.
［100］黄慧玲. 抗肿瘤治疗与高血压［J］. 中国医刊，2019，54（8）：823-828.
HUANG H L. Antineoplastic therapy and hypertension［J］. Chinese Journal of Medicine，2019，54（8）：823-828.
［101］ECONOMOPOULOU P，KENTEPOZIDIS N，KOTSAKISA，et al. Cancer therapy and cardiovascular risk：focus on bevacizumab［J］. Cancer Manag Res，2015，7：133-143. DOI：10.2147/cmar.s77400.
［102］HAN B H，LI K，ZHAO Y Z，et al. Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer：a multicentre，randomised phase Ⅱ trial（ALTER0302）［J］. Br J Cancer，2018，118（5）：654-661. DOI：10.1038/bjc.2017.478.
［103］SUTER T M，EWER M S. Cancer drugs and the heart：importance and management［J］. Eur Heart J，2013，34（15）：1102-1111. DOI：10.1093/eurheartj/ehs181.
［104］FRIEDMAN G D，ASGARI M M，WARTON E M，et al. Antihypertensive drugs and lip cancer in non-hispanic whites［J］. Arch Intern Med，2012，172（16）：1246-1251. DOI：10.1001/archinternmed.2012.2754.
［105］KUNISADA M，MASAKI T，ONO R，et al. Hydrochlorothiazide enhances UVA-induced DNA damage［J］. Photochem Photobiol，2013，89（3）：649-654. DOI：10.1111/php.12048.
［106］FACONTI L，FERRO A，WEBB A J，et al. Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society［J］. J Hum Hypertens，2019，33（4）：257-258. DOI：10.1038/s41371-019-0190-2.
［107］THAKER P H，HAN L Y，KAMAT A A，et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma［J］. Nat Med，2006，12（8）：939-944. DOI：10.1038/nm1447.
［108］MELHEM-BERTRANDT A，CHAVEZ-MACGREGOR M，LEI X D，et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer［J］. J Clin Oncol，2011，29（19）：2645-2652. DOI：10.1200/jco.2010.33.4441.
［109］WANG T，LI Y，LU H L，et al. Β-adrenergic receptors：new target in breast cancer［J］. Asian Pac J Cancer Prev，2016，16（18）：8031-8039. DOI：10.7314/apjcp.2015.16.18.8031.
［110］ROTSHILD V，AZOULAY L，ZARIFEH M，et al. The risk for lung cancer incidence with calcium channel blockers：a systematic review and meta-analysis of observational studies［J］. Drug Saf，2018，41（6）：555-564. DOI：10.1007/s40264-018-0644-4.
［111］LI C I，DALING J R，TANG M T，et al. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years［J］. JAMA Intern Med，2013，173（17）：1629-1637. DOI：10.1001/jamainternmed.2013.9071.
［112］YASUMATSU R，NAKASHIMA T，MASUDA M，et al. Effects of the angiotensin-Ⅰ converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells［J］. J Cancer Res Clin Oncol，2004，130（10）：567-573. DOI：10.1007/s00432-004-0582-7.
［113］LEVER A F，HOLE D J，GILLIS C R，et al. Do inhibitors of angiotensin- Ⅰ -converting enzyme protect against risk of cancer?［J］. Lancet，1998，352（9123）：179-184. DOI：10.1016/S0140-6736（98）03228-0.
［114］PRONTERA C，MARIANI B，ROSSI C，et al. Inhibition of gelatinase A（MMP-2） by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma［J］. Int J Cancer，1999，81（5）：761-766. DOI：10.1002/（sici）1097-0215（19990531）81：5<761：：aid-ijc16>3.0.co;2-1.
［115］HICKS B M，FILION K B，YIN H，et al. Angiotensin converting enzyme inhibitors and risk of lung cancer：population based cohort study［J］. BMJ，2018，363：k4209. DOI：10.1136/bmj.k4209.
［116］SIPAHI I，DEBANNE S M，ROWLAND D Y，et al. Angiotensin-receptor blockade and risk of cancer：meta-analysis of randomised controlled trials［J］. Lancet Oncol，2010，11（7）：627-636. DOI：10.1016/S1470-2045（10）70106-6.
［117］LINK W T，DE FELICE A. An FDA overview of rodent carcinogenicity studies of angiotensin Ⅱ AT-1 receptor blockers：pulmonary adenomas and carcinomas［J］. Regul Toxicol Pharmacol，2014，70（2）：555-563. DOI：10.1016/j.yrtph.2014.09.002.
［118］CHANG C H，LIN J W，WU L C，et al. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus：a nationwide case-control study［J］. J Clin Oncol，2011，29（22）：3001-3007. DOI：10.1200/jco.2011.35.1908.
［119］GIBBONS C H，SCHMIDT P，BIAGGIONI I，et al. The recommendations of a consensus panel for the screening，diagnosis，and treatment of neurogenic orthostatic hypotension and associated supine hypertension［J］. J Neurol，2017，264（8）：1567-1582. DOI：10.1007/s00415-016-8375-x.
［120］FREEMAN R，WIELING W，AXELROD F B，et al. Consensus statement on the definition of orthostatic hypotension，neurally mediated syncope and the postural tachycardia syndrome［J］. Auton Neurosci，2011，161（1/2）：46-48. DOI：10.1016/j.autneu.2011.02.004.
［121］LOAVENBRUCK A，SANDRONI P. Neurogenic orthostatic hypotension：roles of norepinephrine deficiency in its causes，its treatment，and future research directions［J］. Curr Med Res Opin，2015，31（11）：2095-2104. DOI：10.1185/03007995.2015.1087988.
［122］GOLDSTEIN D S，PECHNIK S，HOLMES C，et al. Association between supine hypertension and orthostatic hypotension in autonomic failure［J］. Hypertension，2003，42（2）：136-142. DOI：10.1161/01.HYP.0000081216.11623.C3.
［123］BLEASDALE-BARR K M，MATHIAS C J. Neck and other muscle pains in autonomic failure：their association with orthostatic hypotension［J］. J R Soc Med，1998，91（7）：355-359. DOI：10.1177/014107689809100704.
［124］GIBBONS C H，FREEMAN R. Orthostatic dyspnea：a neglected symptom of orthostatic hypotension［J］. Clin Auton Res，2005，15（1）：40-44. DOI：10.1007/s10286-005-0227-1.
［125］ROBERTSON D，KINCAID D W，HAILE V，et al. The head and neck discomfort of autonomic failure：an unrecognized aetiology of headache［J］. Clin Auton Res，1994，4（3）：99-103. DOI：10.1007/bf01845772.
［126］GUARALDI P，PODA R，CALANDRA-BUONAURA G，et al. Cognitive function in peripheral autonomic disorders［J］. PLoS One，2014，9（1）：e85020. DOI：10.1371/journal.pone.0085020.
［127］CENTI J，FREEMAN R，GIBBONS C H，et al. Effects of orthostatic hypotension on cognition in Parkinson disease［J］. Neurology，2017，88（1）：17-24. DOI：10.1212/WNL.0000000000003452.
［128］李家泰. 《临床药理学》［M］. 3 版. 北京：人民卫生出版社，1991.
［129］WILLIAMS B，MANCIA G，SPIERING W，et al. 2018 practiceguidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology：ESH/ESC Task Force for the management of arterial hypertension［J］. J Hypertens，2018，36（12）：2284-2309. DOI：10.1097/HJH.0000000000001961.
［130］WASSERTHEURER S，KROPF J，WEBER T，et al. A new oscillometric method for pulse wave analysis：comparison with a common tonometric method［J］. J Hum Hypertens，2010，24（8）：498-504. DOI：10.1038/jhh.2010.27.
［131］PUCCI G，BATTISTA F，CROCETTI A，et al. How to measure 24-hour central blood pressure and its potential clinical implications［J］. High Blood Press Cardiovasc Prev，2017，24（2）：141-148. DOI：10.1007/s40292-017-0202-7.
［132］AGABITI-ROSEI E，MANCIA G，O'ROURKE M F，et al. Central blood pressure measurements and antihypertensive therapy：a consensus document［J］. Hypertension，2007，50（1）：154-160. DOI：10.1161/HYPERTENSIONAHA.107.090068.
［133］王新宴，田利源. 高血压的过度诊疗［J］. 世界复合医学，2016，2（1）：73-76. DOI：10.11966/j.issn.2095-994X.2016.02.01.20.
WANG X Y，TIAN L Y. Over diagnosis and over treatment of hypertension［J］. World Journal of Complex Medicine，2016，2（1）：73-76. DOI：10.11966/j.issn.2095-994X.2016.02.01.20.
［134］2013 ESH/ESC guidelines for the management of arterial hypertension：the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension（ESH）and of the European Society of Cardiology（ESC）［J］. Journal of Hypertension，2013，31（7）：1281-1357.
［135］ROMAN M J，DEVEREUX R B，KIZER J R，et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure：the Strong Heart Study［J］. Hypertension，2007，50（1）：197-203. DOI：10.1161/HYPERTENSIONAHA.107.089078.
［136］WILLIAMS B，LACY P S，THOM S M，et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes：principal results of the Conduit Artery Function Evaluation（CAFE） study［J］. Circulation，2006，113（9）：1213-1225. DOI：10.1161/CIRCULATIONAHA.105.595496.

[1]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[2]	XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709.
[3]	CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488.
[4]	BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391.
[5]	ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049.
[6]	YANG Hui. Cooperated and Shared Care: Reflections on Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2711-2714.
[7]	DENG Hongyu, WU Miaomiao, YANG Zheng, HE Yang, ZHU Linlin, ZHAO Qian, DAI Hua, WU Jia, LIAO Xiaoyang, ZHANG Yonggang. Construction of an Innovative Model of Chronic Disease Management in Compact County Medical Alliance with Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2720-2725.
[8]	ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777.
[9]	FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580.
[10]	FEI Min, LEI Si, XU Yan, YE Yun, ZHUO Hui, ZHANG Hui, LUO Yingquan. Association of Obstructive Sleep Apnea-hypopnea Syndrome with Blood Pressure Variability and Heart Rate Variability in Patients with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2459-2468.
[11]	YU Tong, YANG Yi, DU Shihong, DING Zihao, HONG Xiuqin. Correlation of Shearing Force and Estradiol with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2469-2475,2495.
[12]	TIAN Meixiang, ZHANG Zhengyi. Standard Management of Hypertension During the Preparation for Pregnancy [J]. Chinese General Practice, 2023, 26(18): 2190-2194.
[13]	LIU Hai, HUANG Guanhua. The Significance of High Normal Blood Pressure for Children and Adolescents [J]. Chinese General Practice, 2023, 26(18): 2183-2189.
[14]	WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161.
[15]	LIU Rongmei, MAO Yanna, LIU Gendang, ZHAO Yukun, YU Mingyang, ZHAO Qiuping. Number and Costs of Hospitalizations Due to Hypertension and Related Comorbidities and Complications in County-level Healthcare Institutions in a Poverty-stricken County in Henan from 2017 to 2019 [J]. Chinese General Practice, 2023, 26(16): 2020-2026,2035.